Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,627,188
-$205,776 QoQ
Shares Held
28,240
-6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#921
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAHL & GAYNOR INC holds $1,357,498,569 across 6 Drug Manufacturers - General names. BMY ranks #4 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
656,123 | $786,973,675 | |
| 2 | JNJ |
Johnson & Johnson
|
1,970,876 | $500,543,377 | |
| 3 | AMGN |
Amgen Inc
|
186,593 | $67,569,057 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
28,240 | $1,627,188 | |
| 5 | PFE |
Pfizer Inc
|
20,743 | $499,491 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,262 | $285,781 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,627,188 | 28,240 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,832,964 | 30,222 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,684,114 | 31,222 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,782,938 | 39,533 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,043,148 | 44,138 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,686,792 | 44,053 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,542,541 | 44,953 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,341,907 | 45,263 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,846,174 | 44,454 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,416,922 | 44,568 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,226,084 | 43,385 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $2,762,994 | 47,605 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,287,861 | 51,413 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,611,605 | 52,108 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,019,558 | 55,866 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,988,717 | 56,108 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,191,880 | 54,440 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,983,056 | 54,540 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,411,667 | 54,718 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,256,125 | 55,030 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,532,773 | 52,870 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $3,395,005 | 53,778 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,335,849 | 53,778 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $3,299,671 | 54,730 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,302,796 | 56,170 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,138,384 | 56,304 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||